Drs. Pauley and Cha are coinventors with the University of Florida on a patent (University of Florida ID 13439) for a novel carbachol-siRNA conjugate that can be used as a vehicle for altering molecular signals in salivary epithelial cells in patients with Sjo ¨gren's syndrome.
Cytotoxicity of a transferrin-adriamycin conjugate to anthracycline-resistant cells
✍ Scribed by Monika Fritzer; Klara Barabas; Viktoria Szüts; Alajos Berczi; Thomas Szekeres; W Page Faulk; Hans Goldenberg
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- French
- Weight
- 461 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Conjugates of adriamycin coupled to transferrin byglutaraldehyde are cytotoxic to human promyelocytic (HL-60) and erythroleukemic (K562) cells. Growth inhibition of adriamycinsensitive cells, as evaluated by thymidine incorporation and the MlT-assay, was higher for conjugates than for free adriamycin. The cytotoxicity toward adriamycin-resistant K562 and HL-60 cells was 3-fold and more than 10-fold higher, respectively, for the transferrin-adriamycin conjugate than for the free drug. The effect of the conjugate was dependent on its adriamycin content, i.e., on its conjugation number.
📜 SIMILAR VOLUMES
Adriamycin (ADM) can increase sialic acid content in K 562 cells and reduce their susceptibility to NK-mediated lysis. In this report, hypothetical relationship between this resistance and augmentation in sialylation has been investigated. Variations in the time of exposure to ADM showed that I2 hou
A serum-free culture system was established for human KB carcinoma (HeLa) cells that consisted of a chemically defined medium and several growth factors including epidermal growth factor (EGF), insulin, transferrin, hydrocortisone, and ethanolamine. EGF and insulin showed the greatest effects on the